Surbhi Saini

Profile picture
Assistant Professor of Pediatrics, Hematology and Oncology
Hematology and Oncology

phone: (314) 454-6018

Clinical Interests

Hemostatic (bleeding) and thrombotic (clotting) disorders in children


  • MBBS, Government Medical College and Hospital2006


  • Resident, Children's Hospital of Michigan/Wayne State University2008 - 2011
  • Fellow, Children’s National Health System/George Washington University School of Medicine & Health Sciences2011 - 2014
  • Fellow, Pediatric Hemostasis and Thrombosis, Nationwide Children's Hospital/Ohio State University2016 - 2017

Licensure and Board Certification

  • 2011American Board of Pediatrics, General Pediatrics
  • 2015American Board of Pediatrics, Pediatric Hematology/Oncology
  • 2016 - 2021CA, Medical Physician & Surgeon
  • 2017 - 2020PA, Medical Physician & Surgeon
  • 2019 - PresMO, Medical Physician & Surgeon

Honors and Awards

  • Darshi Gupta Memorial Prize - Final Professional Part (II) M.B.B.S examination (Pediatrics)2005
  • Dr.Devinder Sarup Singh Memorial Gold Medal - Final Professional Part (II) M.B.B.S examination2005
  • Dr.Surinder Vadehra Memorial Gold Medal - Final Professional Part (II) M.B.B.S examination2005
  • Panjab University Gold Medal - Final Professional Part (II) M.B.B.S Examination2005
  • Panjab University Gold Medal - Final Professional Part (II) M.B.B.S Examination (General Surgery)2005
  • Panjab University Silver Medal - Final Professional Part (II) M.B.B.S Examination (Internal Medicine)2005
  • Scholarship recipient, 2012 Annual Southeastern Fellows Research Skills Retreat, Duck, North Carolina2012
  • Scholarship recipient, Annual Meeting of the Mid-Atlantic Region III Federally Funded Hemophilia Treatment Centers, Alexandria, Virginia2012 - 2013
  • Certificate of Appreciation for Excellence in Teaching, Pediatric Medical Student Education Curriculum 2013-2014, George Washington University School of Medicine and Health Sciences2014
  • Scholarship recipient, Center for Advanced Training in Hemophilia and Inhibitor Management, Columbus, Ohio2016
  • Scholarship recipient, Haemophilia Academy, Edinburgh, UK2016
  • Abstract Achievement Award, American Society of Hematology, 60th Annual Meeting and Exposition, Atlanta, Georgia2017

Recent Publications view all (10)

  1. Anti-Factor Xa-Based Monitoring of Unfractionated Heparin: Clinical Outcomes in a Pediatric Cohort. J Pediatr. 2019;209:212-219.e1. PMID:30961988 
  2. von Willebrand Disease in Pediatrics: Evaluation and Management. Hematol Oncol Clin North Am. 2019;33(3):425-438. PMID:31030811 
  3. An Open-Label, Single-Arm, Efficacy Study of Tranexamic Acid in Adolescents with Heavy Menstrual Bleeding. J Pediatr Adolesc Gynecol. 2019;32(3):305-311. PMID:30731217 
  4. Treatment-Related Outcomes in Paget-Schroetter Syndrome-A Cross-Sectional Investigation. J Pediatr. 2019;207:226-232.e1. PMCID:PMC6556226  PMID:30528572 
  5. Factor IX inhibitors: Clinical and laboratory profiles of two patients with severe haemophilia B. Haemophilia. 2019;25(2):e126-e129. PMID:30817051 
  6. Small ncRNA Expression-Profiling of Blood from Hemophilia A Patients Identifies miR-1246 as a Potential Regulator of Factor 8 Gene. PLoS One. 2015;10(7):e0132433. PMCID:PMC4503767  PMID:26176629 
  7. Unruptured intracranial aneurysms in children with sickle cell disease: analysis of 18 aneurysms in 5 patients. Neurosurgery. 2015;76(5):531-8; discussion 538-9; quiz 539. PMID:25710108 
  8. Kaposiform lymphangiomatosis: unifying features of a heterogeneous disorder. Pediatr Blood Cancer. 2015;62(5):901-4. PMID:25307772 
  9. Selective IgM deficiency in CD30+ cutaneous lymphoproliferative disorder. J Pediatr Hematol Oncol. 2011;33(4):e156-9. PMID:21516014 
  10. Genetic determinants of immunogenicity to factor IX during the treatment of haemophilia B. Haemophilia. 2015 Mar(21(2)):210-8. PMID:25470321 
Last updated: 12/03/2020
© 2021 by Washington University in St. Louis
One Brookings Drive, St. Louis, MO 63130